Search Results

Vaxxinity, Inc. today announced a research collaboration with the University of Florida’s (UF) Center for Translational Research in Neurodegenerative Disease (CTRND) to support its work on the development of vaccines for neurodegenerative diseases.

Vaxxinity, Inc., a U.S. company pioneering the development of a new class of medicines, announced a collaboration with the University of Central Florida to advance space medicine research.

AviadoBio today announced that its Phase 1/2 ASPIRE-FTD clinical trial is now open and recruiting patients in the United States at The Ohio State University.

2024 is a year of great expectations for the newly established PharmaNutra USA Corp, a US company based in Florida, wholly owned by PharmaNutra S.p.A. and dedicated to marketing and distributing the Group’s products in the United States.

Florida Cancer Specialists & Research Institute, LLC is pleased to welcome hematologist and medical oncologist Juan Garza, MD to the statewide practice.

The Research Park at Florida Atlantic University® is pleased to announce that Instrumentum, an emerging leader in the surgical instrument sterilization field has located its headquarters in the Research Park at Florida Atlantic University®

Florida Senate President Kathleen Passidomo appointed John Couris, president and CEO of Tampa General Hospital, last month to serve as a member of the Health Care Innovation Council, a statewide volunteer organization established this year to advance innovation in health care as part of the Senate’s priority Live Healthy initiative.

DiaCarta, a leading molecular diagnostics company specializing in personalized patient care through liquid biopsy, proudly announced that Florida Health Department selected “using plasma DNA concentration (DiaCarta’s RadTox™ test) for early detection of treatment response and resistance” through the Casey DeSantis Florida Cancer Innovation Fund.